Novelion Therapeutics Inc. (NVLN) Formed Double Bottom; Sellers Are Thriving

April 19, 2018 - By Nellie Frank

The chart of Novelion Therapeutics Inc. (NVLN) shows a double bottom with $4.16 target or 4.00 % below today’s $4.33 share price. The 8 months chart pattern indicates high risk for the $80.99M company. It was reported on Apr, 19 by Finviz.com. If the $4.16 price target is reached, the company will be worth $3.24M less. Double bottoms are rare but powerful chart patterns.

The stock increased 2.85% or $0.12 during the last trading session, reaching $4.33. About 68,571 shares traded or 33.88% up from the average. Novelion Therapeutics Inc. (NASDAQ:NVLN) has declined 68.94% since April 19, 2017 and is downtrending. It has underperformed by 80.49% the S&P500.

Novelion Therapeutics Inc. (NASDAQ:NVLN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.